These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15070976)
1. Bezafibrate and simvastatin: different beneficial effects for different therapeutic aims. Tenenbaum A; Fisman EZ; Motro M J Clin Endocrinol Metab; 2004 Apr; 89(4):1978; author reply 1978-9. PubMed ID: 15070976 [No Abstract] [Full Text] [Related]
2. [Guideline for management of lipid metabolism]. Ishibashi S Nihon Rinsho; 2002 Sep; 60 Suppl 9():675-8. PubMed ID: 12387068 [No Abstract] [Full Text] [Related]
3. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661 [No Abstract] [Full Text] [Related]
4. [Ezetimibe: caution in the face of doubt]. Araujo F; Mateo de Castro J; Encinas Barrios C Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227 [No Abstract] [Full Text] [Related]
5. [Current evidence about lipid-lowering therapy and coronary plaque]. Otake H; Hirata K Nihon Rinsho; 2011 Sep; 69 Suppl 7():95-102. PubMed ID: 22518972 [No Abstract] [Full Text] [Related]
6. [Drug combination therapies for patients with hyperlipidemia and its significance]. Onuma T; Kawamori R Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133 [No Abstract] [Full Text] [Related]
8. Successful treatment of xanthoma disseminatum with simvastatin. Lee EH; Kang TW; Kim SC J Dermatol; 2011 Oct; 38(10):1015-7. PubMed ID: 21592199 [No Abstract] [Full Text] [Related]
9. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients. Branchi A; Rovellini A; Fiorenza AM; Sommariva D Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386 [TBL] [Abstract][Full Text] [Related]
10. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. Triolo M; Annema W; de Boer JF; Tietge UJ; Dullaart RP Eur J Clin Invest; 2014; 44(3):240-8. PubMed ID: 24325778 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096 [TBL] [Abstract][Full Text] [Related]
14. Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus. Kappelle PJ; Ahnström J; Dikkeschei BD; de Vries R; Sluiter WJ; Wolffenbuttel BH; van Tol A; Nielsen LB; Dahlbäck B; Dullaart RP Atherosclerosis; 2010 Nov; 213(1):247-50. PubMed ID: 20828695 [TBL] [Abstract][Full Text] [Related]
15. When 4.5 million people become patients. Drug Ther Bull; 2014 Aug; 52(8):85. PubMed ID: 25125552 [No Abstract] [Full Text] [Related]
16. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia. Smith DH; Neutel JM; Jankelow D; Myburgh DP S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379 [TBL] [Abstract][Full Text] [Related]
17. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia]. Bruckert E; Truffert J; De Gennes JL Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528 [TBL] [Abstract][Full Text] [Related]
18. Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome. Cummings MH; Watts GF Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():383-5. PubMed ID: 7979108 [No Abstract] [Full Text] [Related]